Bare Financial Services’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.1K Buy
259
+88
+51% +$4.78K ﹤0.01% 547
2026
Q1
$10.7K Buy
171
+80
+88% +$6.4K ﹤0.01% 309
2025
Q4
$8.68K Sell
91
-36
-28% -$3.53K ﹤0.01% 295
2025
Q3
$12.4K Buy
127
+39
+44% +$4.04K ﹤0.01% 184
2025
Q2
$9.45K Buy
88
+66
+300% +$6.68K ﹤0.01% 195
2025
Q1
$2.22K Buy
+22
New +$2.21K ﹤0.01% 236

Other funds holding BSX

Bare Financial Services's BSX Position: Q2 2026 in Review

Bare Financial Services increased its Boston Scientific (BSX) stake by 51% in Q2 2026, buying an estimated $4.78K and bringing the position to 259 shares worth $11.1K. The position accounts for ﹤0.01% of the portfolio, ranked #547.

Bare Financial Services first reported a position in BSX in Q1 2025 and has held it in 6 quarters since. The position peaked at $12.4K in Q3 2025. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Bare Financial Services held 259 shares of Boston Scientific worth $11.1K as of Q2 2026.
  • Bare Financial Services bought 88 Boston Scientific shares in Q2 2026, an estimated $4.78K.
  • Boston Scientific made up ﹤0.01% of Bare Financial Services's portfolio in Q2 2026, its #547 holding.
  • Bare Financial Services first reported a position in Boston Scientific in Q1 2025 and has held it in 6 quarters since.
  • Bare Financial Services's Boston Scientific position peaked at $12.4K in Q3 2025.
  • 1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Bare Financial Services's 13F filing for Q2 2026, filed 27 Jul 2026.